Lander ES. Brave New Genome. N Engl J Med. 2015;373(1):5-8. doi:10.1056/NEJMp1506446
Won HH, Natarajan P, Dobbyn A, et al. Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease. PLoS Genet. 2015;11(10):e1005622. doi:10.1371/journal.pgen.1005622
Poulsen JB, Lescai F, Grove J, et al. High-Quality Exome Sequencing of Whole-Genome Amplified Neonatal Dried Blood Spot DNA. PLoS One. 2016;11(4):e0153253. doi:10.1371/journal.pone.0153253
Walsh EC, Mather KA, Schaffner SF, et al. An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet. 2003;73(3):580-90. doi:10.1086/378101
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33(2):177-82. doi:10.1038/ng1071
Berger MF, Garraway LA. Applications of genomics in melanoma oncogene discovery. Hematol Oncol Clin North Am. 2009;23(3):397-414, vii. doi:10.1016/j.hoc.2009.03.005
Getz G, Höfling H, Mesirov JP, et al. Comment on "The consensus coding sequences of human breast and colorectal cancers". Science. 2007;317(5844):1500. doi:10.1126/science.1138764
Pedersen JS, Bejerano G, Siepel A, et al. Identification and classification of conserved RNA secondary structures in the human genome. PLoS Comput Biol. 2006;2(4):e33. doi:10.1371/journal.pcbi.0020033
George RE, Sanda T, Hanna M, et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature. 2008;455(7215):975-8. doi:10.1038/nature07397
Gewurz BE, Towfic F, Mar JC, et al. Genome-wide siRNA screen for mediators of NF-κB activation. Proc Natl Acad Sci U S A. 2012;109(7):2467-72. doi:10.1073/pnas.1120542109